Dr. Martens plc

LSE DOCS.L

Dr. Martens plc Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -32.17 M

Dr. Martens plc Net Cash Used For Investing Activities is USD -32.17 M for the year ending March 31, 2024, a 50.01% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Dr. Martens plc Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -64.36 M, a -96.01% change year over year.
Dr. Martens plc Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -32.83 M, a -37.76% change year over year.
Dr. Martens plc Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -23.83 M, a 12.29% change year over year.
Dr. Martens plc Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -27.17 M, a -21.92% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

LSE: DOCS.L

Dr. Martens plc

CEO	Mr. Kenneth Wilson
IPO Date	Jan. 29, 2021
Location	United Kingdom
Headquarters	28 Jamestown Road
Employees	2,630
Sector	Consumer Discretionary
Industries Footwear Apparel & Fashion Eyewear Luxury Goods

Description

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Key trends

Past 5 years